专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

141. 发明申请

US20120249000A1 LED DIMMER CIRCUIT 有权
标题翻译： LED调光电路
公开(公告)号：US20120249000A1
公开(公告)日：2012-10-04
申请号：US13432798
申请日：2012-03-28
申请人： Shuhei Kawai , Tomoyuki Goto , Feng Xu
发明人： Shuhei Kawai , Tomoyuki Goto , Feng Xu
IPC分类号： H05B37/02
CPC分类号： H05B33/0851 , H05B33/0815 , H05B33/0818
摘要： A TRIAC dimmer gates an AC waveform from an AC power source in proportion to a control signal and outputs a TRIAC pulse having part of the waveform missing. The TRIAC pulse is rectified and is applied to an LED array and the drive current flowing to the LED array is detected at a current detection resistor. The drive current value and a predetermined value are compared at a comparator and in accordance with the comparison result thereof the control transistor is turned off. Then, the TRIAC pulse is converted to a DC voltage signal and in accordance with the obtained DC voltage signal the drive current value or the predetermined value input by the comparator are changed. Furthermore, instead of the TRIAC pulse, a PWM pulse supplied from an external source may also be utilized.
摘要翻译： TRIAC调光器根据控制信号与交流电源门控交流波形，并输出一部分波形丢失的TRIAC脉冲。 TRIAC脉冲被整流并施加到LED阵列，并且在电流检测电阻器处检测流到LED阵列的驱动电流。驱动电流值和预定值在比较器处进行比较，并根据其比较结果控制晶体管截止。然后，将TRIAC脉冲转换成直流电压信号，并且根据获得的直流电压信号，改变由比较器输入的驱动电流值或预定值。此外，也可以使用从外部源提供的PWM脉冲来代替TRIAC脉冲。

142. 发明授权

US08246668B2 Controllable infrared bioeffect system 失效
标题翻译：可控红外生物效应系统
公开(公告)号：US08246668B2
公开(公告)日：2012-08-21
申请号：US12742811
申请日：2009-04-14
申请人： Xinghua Gao , Ruiqun Qi , Feng Xu , Hongduo Chen
发明人： Xinghua Gao , Ruiqun Qi , Feng Xu , Hongduo Chen
IPC分类号： A61N5/06
CPC分类号： A61N5/06
摘要： The present invention belongs to the technical field of infrared research and application in biomedicine. In particular, it refers to an apparatus of bio-effect system with the use of controllable infrared wave. The invention includes a shell (16); a infrared source (1) inside of the shell (16), the first group of filter mounting plate (2), convex lens (3), concave lens (4), the second groups of filter mounting plate (5), cable receptor device (6) and execution end (18); the first group of filter mounting plate (2) and the second group of filter mounting plate (5) are in line with the central axis; the described convex lens (3) is installed between the infrared source (1) and concave lens (4); the described first group of filter mounting plate (2) and the second group of filter mounting plate (5) are located between the concave lens (4) and the cable receptor device (6); the described second group of filter mounting plate (2) is installed with the first filter (23); the second group of filter mounting plate (5) is installed with the second filter (7). The invention is simple in structure. It is used to irradiate the test material, by selecting certain wavelength of IF-IR.
摘要翻译：本发明属于生物医学红外线研究与应用技术领域。特别是指使用可控红外波的生物效应系统的装置。本发明包括壳体（16）; 壳体（16）内的红外源（1），第一组滤光片安装板（2），凸透镜（3），凹透镜（4），第二组滤光片安装板（5），电缆接收器装置（6）和执行端（18）; 第一组过滤器安装板（2）和第二组过滤器安装板（5）与中心轴线一致; 所述凸透镜（3）安装在红外源（1）和凹透镜（4）之间; 所述第一组过滤器安装板（2）和第二组过滤器安装板（5）位于凹透镜（4）和电缆接收装置（6）之间; 所述第二组过滤器安装板（2）安装有第一过滤器（23）; 第二组过滤器安装板（5）安装有第二过滤器（7）。本发明结构简单。通过选择一定波长的IF-IR，用于照射测试材料。

143. 外观设计

USD649130S1 Mobile phone 有权
公开(公告)号：USD649130S1
公开(公告)日：2011-11-22
申请号：US29364489
申请日：2010-06-24
申请人： Xiaofei Ge , Feng Xu
设计人： Xiaofei Ge , Feng Xu

144. 发明授权

US07943350B2 Methods for degrading lignocellulosic materials 有权
标题翻译：降解木质纤维素材料的方法
公开(公告)号：US07943350B2
公开(公告)日：2011-05-17
申请号：US11821438
申请日：2007-06-22
申请人： Elena Vlasenko , Joel Cherry , Feng Xu
发明人： Elena Vlasenko , Joel Cherry , Feng Xu
IPC分类号： C12P19/04
CPC分类号： C12P19/14 , C12P7/06 , C12P13/04 , Y02E50/17 , Y02E50/343
摘要： The present invention relates to methods for degrading a lignocellulosic material, comprising: treating the lignocellulosic material with an effective amount of one or more cellulolytic enzymes in the presence of at least one surfactant selected from the group consisting of a secondary alcohol ethoxylate, fatty alcohol ethoxylate, nonylphenol ethoxylate, tridecyl ethoxylate, and polyoxyethylene ether, wherein the presence of the surfactant increases the degradation of lignocellulosic material compared to the absence of the surfactant. The present invention also relates to methods for producing an organic substance, comprising: (a) saccharifying a lignocellulosic material with an effective amount of one or more cellulolytic enzymes in the presence of at least one surfactant selected from the group consisting of a secondary alcohol ethoxylate, fatty alcohol ethoxylate, nonylphenol ethoxylate, tridecyl ethoxylate, and polyoxyethylene ether, wherein the presence of the surfactant increases the degradation of lignocellulosic material compared to the absence of the surfactant; (b) fermenting the saccharified lignocellulosic material of step (a) with one or more fermenting microorganisms; and (c) recovering the organic substance from the fermentation.
摘要翻译：本发明涉及降解木质纤维素材料的方法，包括：在至少一种表面活性剂存在下，用有效量的一种或多种纤维素分解酶处理木质纤维素材料，所述表面活性剂选自仲醇乙氧基化物，脂肪醇乙氧基化物，壬基酚乙氧基化物，十三烷基乙氧基化物和聚氧乙烯醚，其中与不存在表面活性剂相比，表面活性剂的存在增加了木质纤维素材料的降解。本发明还涉及生产有机物质的方法，其包括：（a）在至少一种表面活性剂存在下，用有效量的一种或多种纤维素分解酶对木质纤维素材料进行糖化，所述表面活性剂选自仲醇乙氧基化物，脂肪醇乙氧基化物，壬基酚乙氧基化物，十三烷基乙氧基化物和聚氧乙烯醚，其中与不存在表面活性剂相比，表面活性剂的存在增加了木质纤维素材料的降解; （b）用一种或多种发酵微生物发酵步骤（a）的糖化木质纤维素材料; 和（c）从发酵中回收有机物质。

145. 发明申请

US20100324634A1 CONTROLABLE INFRARED BIOEFFECT SYSTEM 失效
标题翻译：可控红外生物系统
公开(公告)号：US20100324634A1
公开(公告)日：2010-12-23
申请号：US12742811
申请日：2009-04-14
申请人： Xinghua Gao , Ruiqun Qi , Feng Xu , Hongduo Chen
发明人： Xinghua Gao , Ruiqun Qi , Feng Xu , Hongduo Chen
IPC分类号： A61N5/06
CPC分类号： A61N5/06
摘要： The present invention belongs to the technical field of infrared research and application in biomedicine. In particular, it refers to an apparatus of bio-effect system with the use of controllable infrared wave. The invention includes a shell (16); a infrared source (1) inside of the shell (16), the first group of filter mounting plate (2), convex lens (3), concave lens (4), the second groups of filter mounting plate (5), cable receptor device (6) and execution end (18); the first group of filter mounting plate (2) and the second group of filter mounting plate (5) are in line with the central axis; the described convex lens (3) is installed between the infrared source (1) and concave lens (4); the described first group of filter mounting plate (2) and the second group of filter mounting plate (5) are located between the concave lens (4) and the cable receptor device (6); the described second group of filter mounting plate (2) is installed with the first filter (23); the second group of filter mounting plate (5) is installed with the second filter (7). The invention is simple in structure. It is used to irradiate the test material, by selecting certain wavelength of IF-IR.
摘要翻译：本发明属于生物医学红外线研究与应用技术领域。特别是指使用可控红外波的生物效应系统的装置。本发明包括壳体（16）; 壳体（16）内的红外源（1），第一组滤光片安装板（2），凸透镜（3），凹透镜（4），第二组滤光片安装板（5），电缆接收器装置（6）和执行端（18）; 第一组过滤器安装板（2）和第二组过滤器安装板（5）与中心轴线一致; 所述凸透镜（3）安装在红外源（1）和凹透镜（4）之间; 所述第一组过滤器安装板（2）和第二组过滤器安装板（5）位于凹透镜（4）和电缆接收装置（6）之间; 所述第二组过滤器安装板（2）安装有第一过滤器（23）; 第二组过滤器安装板（5）安装有第二过滤器（7）。本发明结构简单。通过选择一定波长的IF-IR，用于照射测试材料。

146. 发明申请

US20100273734A1 Derivatives of Hyaluronic Acids 审中-公开
标题翻译：透明质酸衍生物
公开(公告)号：US20100273734A1
公开(公告)日：2010-10-28
申请号：US11680057
申请日：2007-02-28
申请人： Feng Xu
发明人： Feng Xu
IPC分类号： A61K31/728 , C07H5/06 , A61K8/73 , A61P17/02 , A61P17/14 , A61P19/10 , A61P27/02 , A61P35/00 , A61Q19/00 , A61Q90/00
CPC分类号： A61K31/728 , C08B37/0072
摘要： The present invention relates to methods for preparing a derivative of a hyaluronic acid, comprising: (a) mixing a liquid solution comprising the hyaluronic acid and a diamine, a polyamine, or a combination thereof, at a pH suitable to form an imine; (b) reducing the imine to an amine with a reductant at a pH suitable to produce the derivative of the hyaluronic acid; and (c) recovering the derivative of the hyaluronic acid. The present invention also relates to isolated derivatives of a hyaluronic acid, comprising the hyaluronic acid and a diamine, a polyamine, or a combination thereof.
摘要翻译：本发明涉及制备透明质酸衍生物的方法，包括：（a）在适于形成亚胺的pH下混合包含透明质酸和二胺，多胺或其组合的液体溶液; （b）在适于产生透明质酸衍生物的pH下，将亚胺还原为具有还原剂的胺; 和（c）回收透明质酸的衍生物。本发明还涉及透明质酸的分离衍生物，其包含透明质酸和二胺，多胺或其组合。

147. 发明申请

US20100267676A1 GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAB RECEPTOR LIGANDS 有权
标题翻译： γ-氨基丁酸衍生物作为GABAB受体配体
公开(公告)号：US20100267676A1
公开(公告)日：2010-10-21
申请号：US12762152
申请日：2010-04-16
申请人： Feng Xu , Mark A. Gallop , Ge Peng , Thu Phan , Usha Dilip , David J. Wustrow
发明人： Feng Xu , Mark A. Gallop , Ge Peng , Thu Phan , Usha Dilip , David J. Wustrow
IPC分类号： A61K31/66 , C07C53/23 , A61K31/196 , A61K31/195 , C07D213/04 , A61K31/44 , C07D235/04 , A61K31/4184 , C07D333/40 , A61K31/381 , C07D239/24 , A61K31/505 , C07C255/60 , A61K31/277 , C07C63/70 , C07D307/38 , A61K31/341 , C07D277/02 , A61K31/426 , C07D263/02 , A61K31/421 , A61P1/04 , A61P11/00 , A61P13/10 , A61P25/00
CPC分类号： C07C255/59 , C07C229/34 , C07C229/38 , C07C229/42 , C07C229/58 , C07C229/60 , C07C233/81 , C07C237/30 , C07C255/58 , C07C311/21 , C07C317/48 , C07D213/30 , C07D213/74 , C07D333/24 , C07D333/70 , C07F9/301 , C07F9/306 , C07F9/58
摘要： Gamma-amino-butyric acid derivatives that are GABAB receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed.
摘要翻译：公开了作为GABA B受体配体的γ-氨基丁酸衍生物，包含该衍生物的药物组合物，以及使用这些衍生物的方法及其药物组合物治疗疾病。

148. 发明申请

US20100120727A1 Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof 审中-公开
标题翻译：盐酸前体药物，结合物和盐及其使用方法
公开(公告)号：US20100120727A1
公开(公告)日：2010-05-13
申请号：US12617574
申请日：2009-11-12
申请人： Feng Xu
发明人： Feng Xu
IPC分类号： A61K31/60 , C07C229/26 , C07C315/00 , C07C69/76 , A61K31/195 , C07C229/00 , A61K31/22 , A61P35/04
CPC分类号： A61K31/195 , A61K31/21 , A61K31/282 , A61K38/21 , A61K45/06 , A61K47/55 , C07C229/26 , C07C271/22 , C07F9/2408 , C07F9/2458 , A61K2300/00
摘要： In one aspect, the present invention provides a composition of a covalent conjugate of an eflornithine analog with an anti-inflammatory drug. In another aspect, the present invention provides a composition of an eflornithine prodrug. In another aspect, the present invention provides a composition of an eflornithine or its derivatives aspirin salt. In another aspect, the present invention provides methods for treating or preventing cancer using the conjugates or salts of eflornithine analogs or eflornithine prodrugs.
摘要翻译：一方面，本发明提供了一种eflornithine类似物与抗炎药物的共价缀合物的组合物。在另一方面，本发明提供了一种依菲氯铵前体药物的组合物。另一方面，本发明提供了一种依芬膦酸或其衍生物阿司匹林盐的组合物。另一方面，本发明提供了使用eflornithine类似物或eflornithine前药的缀合物或盐治疗或预防癌症的方法。

149. 发明申请

US20090325784A1 Hydrocarbon Dehydrogenation with Zirconia 有权
标题翻译：碳氢脱氢与氧化锆
公开(公告)号：US20090325784A1
公开(公告)日：2009-12-31
申请号：US12488998
申请日：2009-06-22
申请人： Wei Pan , Stephen M. Casey , Bryan K. Glover , Feng Xu
发明人： Wei Pan , Stephen M. Casey , Bryan K. Glover , Feng Xu
IPC分类号： B01J20/34 , C07C5/333
CPC分类号： B01J23/92 , B01J21/20 , B01J23/10 , B01J37/0221 , B01J38/12 , C07C5/3332 , C07C2521/06 , C07C2521/10 , C07C2523/02 , C07C2523/10 , C07C2523/12 , C10G2300/1081 , C10G2400/20 , C10G2400/22 , Y02P20/584 , C07C11/02
摘要： A method for obtaining an olefin is disclosed, the method comprising subjecting a paraffin to dehydrogenation in the absence of oxygen and in the presence of a catalyst comprising a crystalline substrate, to obtain an olefin. The catalyst includes an inert stabilizing agent for maintaining the catalyst crystal structure. The catalyst may be regenerated by being subjected, in air, to a temperature between about 550° C. and about 750° C, for a period of time between about 15 minutes and about 4 hours.
摘要翻译：公开了一种获得烯烃的方法，该方法包括在不存在氧的情况下和在含有结晶底物的催化剂的存在下使石蜡脱氢以获得烯烃。催化剂包括用于维持催化剂晶体结构的惰性稳定剂。催化剂可以通过在空气中在约550℃和约750℃之间的温度下在约15分钟至约4小时之间的时间内再生。

150. 发明申请

US20090312424A1 AROMATIC PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF 审中-公开
标题翻译：丙泊酚的组合物及其用途
公开(公告)号：US20090312424A1
公开(公告)日：2009-12-17
申请号：US12498622
申请日：2009-07-07
申请人： Mark A. Gallop , Feng Xu
发明人： Mark A. Gallop , Feng Xu
IPC分类号： A61K31/196 , A61P43/00
CPC分类号： C07C271/28
摘要： Prodrugs of propofol, methods of making prodrugs of propofol, pharmaceutical compositions of prodrugs of propofol and methods of using prodrugs of propofol and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as migraine headache pain and post-chemotherapy or post-operative surgery nausea and vomiting are disclosed herein.
摘要翻译：丙泊酚的前药，制备丙泊酚前药的方法，丙泊酚前药的药物组合物和使用异丙酚前药的方法及其药物组合物治疗或预防疾病或病症如偏头痛头痛和化疗后或术后手术恶心和呕吐。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式